JP2004528385A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528385A5 JP2004528385A5 JP2002589442A JP2002589442A JP2004528385A5 JP 2004528385 A5 JP2004528385 A5 JP 2004528385A5 JP 2002589442 A JP2002589442 A JP 2002589442A JP 2002589442 A JP2002589442 A JP 2002589442A JP 2004528385 A5 JP2004528385 A5 JP 2004528385A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- compound
- free
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 14
- -1 1,2-dichlorophenyl Chemical group 0.000 claims 8
- 150000003839 salts Chemical group 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 claims 3
- 125000001506 1,2,3-triazol-5-yl group Chemical group [H]N1N=NC([H])=C1[*] 0.000 claims 2
- 125000001414 1,2,4-triazol-5-yl group Chemical group [H]N1N=C([H])N=C1[*] 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims 1
- 101800004538 Bradykinin Proteins 0.000 claims 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims 1
- 102100035792 Kininogen-1 Human genes 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29082701P | 2001-05-14 | 2001-05-14 | |
| PCT/EP2002/005240 WO2002092556A1 (en) | 2001-05-14 | 2002-05-13 | Sulfonamide derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004528385A JP2004528385A (ja) | 2004-09-16 |
| JP2004528385A5 true JP2004528385A5 (enExample) | 2005-12-22 |
| JP4150597B2 JP4150597B2 (ja) | 2008-09-17 |
Family
ID=23117717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002589442A Expired - Fee Related JP4150597B2 (ja) | 2001-05-14 | 2002-05-13 | スルホンアミド誘導体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7109203B2 (enExample) |
| EP (1) | EP1389183B1 (enExample) |
| JP (1) | JP4150597B2 (enExample) |
| CN (1) | CN1268610C (enExample) |
| AR (1) | AR035891A1 (enExample) |
| AT (1) | ATE459598T1 (enExample) |
| BR (1) | BR0209386A (enExample) |
| CA (1) | CA2443721A1 (enExample) |
| DE (1) | DE60235536D1 (enExample) |
| ES (1) | ES2340664T3 (enExample) |
| PE (1) | PE20021158A1 (enExample) |
| PT (1) | PT1389183E (enExample) |
| WO (1) | WO2002092556A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
| US6214807B1 (en) * | 1999-06-22 | 2001-04-10 | Cv Therapeutics, Inc. | C-pyrazole 2A A receptor agonists |
| US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
| US20020012946A1 (en) * | 2000-02-23 | 2002-01-31 | Luiz Belardinelli | Method of identifying partial agonists of the A2A receptor |
| KR20050026546A (ko) * | 2002-07-29 | 2005-03-15 | 씨브이 쎄러퓨틱스, 인코포레이티드 | Ａ2ａ 수용체 작용제를 이용한 심근 관류 조영 |
| US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
| US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
| AU2003299757A1 (en) * | 2002-12-19 | 2004-07-14 | Elan Pharmaceuticals Inc. | Substituted n-phenyl sulfonamide bradykinin antagonists |
| US7655636B2 (en) * | 2004-10-20 | 2010-02-02 | Gilead Palo Alto, Inc. | Use of A2A adenosine receptor agonists |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| US7732595B2 (en) | 2006-02-03 | 2010-06-08 | Gilead Palo Alto, Inc. | Process for preparing an A2A-adenosine receptor agonist and its polymorphs |
| US20070299089A1 (en) * | 2006-06-22 | 2007-12-27 | Cv Therapeutics, Inc. | Use of A2A Adenosine Receptor Agonists in the Treatment of Ischemia |
| US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
| BRPI0716174A2 (pt) * | 2006-09-01 | 2013-09-24 | Cv Therapeutics Inc | mÉtodos e composiÇÕes para aumentar a tolerabilidade de paciente durante mÉtodos de imagem do miocÁrdio. |
| JP2011502101A (ja) * | 2006-09-29 | 2011-01-20 | ギリアード・パロ・アルト・インコーポレイテッド | 肺疾患の病歴を有する患者における心筋画像化法 |
| US20080267861A1 (en) * | 2007-01-03 | 2008-10-30 | Cv Therapeutics, Inc. | Myocardial Perfusion Imaging |
| KR101673621B1 (ko) * | 2008-03-24 | 2016-11-07 | 노파르티스 아게 | 아릴술폰아미드-계 매트릭스 메탈로프로테아제 억제제 |
| RU2011115815A (ru) * | 2008-09-29 | 2012-11-10 | Гайлид Сайэнсиз, Инк. (Us) | Комбинации средства, регулирующего частоту сердечных сокращений и агониста а-2-альфа рецепторов для применения в способах мультидетекторной компьютерной томографии |
| EP2316820A1 (en) | 2009-10-28 | 2011-05-04 | Dompe S.p.A. | 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
| CA2867043A1 (en) | 2012-05-03 | 2013-11-07 | Novartis Ag | L-malate salt of 2,7-diaza-spiro[4.5]dec-7-yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
| SMT201700161T1 (it) | 2013-06-14 | 2017-05-08 | Dompe Farm Spa | Antagonisti del recettore della bradichinina e composizioni farmaceutiche che li contengono |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE120047C (enExample) * | ||||
| FR2743562B1 (fr) * | 1996-01-11 | 1998-04-03 | Sanofi Sa | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant |
| WO2001024786A1 (en) * | 1999-05-13 | 2001-04-12 | Shionogi & Co., Ltd. | Preventive or therapeutic drugs for diabetes |
| GB9913079D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
-
2002
- 2002-05-13 WO PCT/EP2002/005240 patent/WO2002092556A1/en not_active Ceased
- 2002-05-13 CN CNB028098900A patent/CN1268610C/zh not_active Expired - Fee Related
- 2002-05-13 DE DE60235536T patent/DE60235536D1/de not_active Expired - Fee Related
- 2002-05-13 BR BR0209386-3A patent/BR0209386A/pt not_active IP Right Cessation
- 2002-05-13 JP JP2002589442A patent/JP4150597B2/ja not_active Expired - Fee Related
- 2002-05-13 AR ARP020101737A patent/AR035891A1/es unknown
- 2002-05-13 US US10/475,420 patent/US7109203B2/en not_active Expired - Fee Related
- 2002-05-13 PT PT02742997T patent/PT1389183E/pt unknown
- 2002-05-13 ES ES02742997T patent/ES2340664T3/es not_active Expired - Lifetime
- 2002-05-13 EP EP02742997A patent/EP1389183B1/en not_active Expired - Lifetime
- 2002-05-13 AT AT02742997T patent/ATE459598T1/de not_active IP Right Cessation
- 2002-05-13 CA CA002443721A patent/CA2443721A1/en not_active Abandoned
- 2002-05-14 PE PE2002000401A patent/PE20021158A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528385A5 (enExample) | ||
| JP2005053931A5 (enExample) | ||
| JP2008511601A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| WO2003037881A1 (en) | α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE | |
| JP2010526146A5 (enExample) | ||
| JP2006513268A5 (ja) | アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体 | |
| JP2003532731A5 (enExample) | ||
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP2008505117A5 (enExample) | ||
| JP2004535466A5 (enExample) | ||
| JP2004533479A5 (enExample) | ||
| JP2005530811A5 (enExample) | ||
| HUP0300304A2 (hu) | 2-es helyzetben szubsztituált 8,8a-dihidro-indeno[1,2-D]-tiazol-származékok, eljárás a vegyületek előállítására és gyógyszerként történő alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
| RU2005121908A (ru) | Производные зн-хиназолин-4-она | |
| JP2007515467A5 (enExample) | ||
| JP2002526522A5 (enExample) | ||
| JP2012511558A5 (enExample) | ||
| JP2005533760A5 (enExample) | ||
| JP2018502911A5 (enExample) | ||
| MX2007013606A (es) | (3,4-dihidro-quinazolin2-il)-(2-ariloxi-etil)-aminas que tienen una actividad en el receptor 5-ht. | |
| JP2002538148A (ja) | 多環２−アミノチアゾール系、その製造方法およびそれを含む医薬 | |
| JP2002538117A (ja) | 肥満の予防または治療のための医薬の製造のための多環２−アミノチアゾール系の使用 | |
| JP2002538101A (ja) | 肥満症を予防または治療するための薬剤の製造における多環式チアゾール系の使用 | |
| JP2004502767A5 (enExample) |